Perspective Therapeutics (CATX) Long-Term Debt Repayments (2010 - 2026)
Perspective Therapeutics recorded quarterly Long-Term Debt Repayments of $15000.0 in Q1 2026, up 15.38% quarter-over-quarter from $13000.0 in Q4 2025, and up 15.38% year-over-year from $13000.0 in Q1 2025.
Perspective Therapeutics' Long-Term Debt Repayments history runs 6 years deep, the most recent figure standing at $15000.0 for Q1 2026.
- In Q1 2026, Long-Term Debt Repayments rose 15.38% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $54000.0 (up 10.2% YoY), while the FY2025 annual figure was $52000.0, up 8.33% from the prior year.
- Long-Term Debt Repayments came in at $15000.0 for Q1 2026 at Perspective Therapeutics, up from $13000.0 in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $21000.0 in Q3 2023 to a low of $8000.0 in Q2 2024.
- A 4-year average of $14076.9 and a median of $13000.0 in 2025 frame the typical range for Long-Term Debt Repayments.
- Across the five-year window, Long-Term Debt Repayments tumbled 60.0% in 2024 and surged 62.5% in 2025, its largest moves.
- Perspective Therapeutics' Long-Term Debt Repayments stood at $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then advanced by 8.33% to $13000.0 in 2025, then increased by 15.38% to $15000.0 in 2026.
- According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $15000.0, $13000.0, and $13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Jun 30, 2011 | 141,661.00 |
| Jun 30, 2011 | 141,661.00 |
| Mar 31, 2011 | 13,001.00 |
| Mar 31, 2011 | 13,001.00 |
| Dec 31, 2010 | 13,414.00 |
| Dec 31, 2010 | 13,414.00 |
| Sep 30, 2010 | 11,919.00 |
| Sep 30, 2010 | 11,919.00 |